ArticleOncotarget2020

Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients.

Mara W Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.